Tomasz Pielak

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

Jesper Eugen‐Olsen, Ove Andersen, Allan Linneberg et al. · Journal of Internal Medicine · 2010 · 372 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events

Danny J. Eapen, Pankaj Manocha, Nima Ghasemzadeh et al. · Journal of the American Heart Association · 2014 · 134 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: <scp>A</scp> sub‐analysis of a randomized, placebo‐controlled, double‐blind, crossover trial

Bernt Johan von Scholten, Frederik Persson, Signe Rosenlund et al. · Diabetes Obesity and Metabolism · 2017 · 58 citations

Medicine, Endocrinology, Pharmacology +15

Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease

Girum Mekonnen, Michel Corban, Olivia Y. Hung et al. · Atherosclerosis · 2014 · 55 citations

Medicine, Cardiology, Clinical Cardiology +11

Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death

Nima Ghasemzadeh, Salim S. Hayek, Yi‐An Ko et al. · Circulation Cardiovascular Quality and Outcomes · 2017 · 30 citations · Full text

Medicine, Cardiology, Immunology +17